Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progressive”

2,612 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,612 results

Large-scale testing (Phase 3)Study completedNCT01721746
What this trial is testing

Compare BMS-936558 to the Physician's Choice of Either Dacarbazine or Carboplatin and Paclitaxel in Advanced Melanoma Patients That Have Progressed Following Anti-CTLA-4 Therapy (CheckMate 037)

Who this might be right for
Unresectable or Metastatic Melanoma
Bristol-Myers Squibb 405
Testing effectiveness (Phase 2)Active Not RecruitingNCT04049669
What this trial is testing

Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG

Who this might be right for
GlioblastomaMedulloblastomaEpendymoma+1 more
Theodore S. Johnson 130
Early research (Phase 1)Study completedNCT00098761
What this trial is testing

VNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Pediatric Brain Tumor Consortium 42
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07222956
What this trial is testing

Remibrutinib Using MR Imaging in Relapsing or Progressive MS

Who this might be right for
Multiple Sclerosis (MS) - Relapsing-remittingMultiple Sclerosis (MS) Secondary ProgressiveMultiple Sclerosis (MS) Primary Progressive
Moein Amin 20
Testing effectiveness (Phase 2)UnknownNCT00303745
What this trial is testing

Irinotecan With or Without Capecitabine as Second-Line Therapy in Treating Older Patients With Progressive, Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

Who this might be right for
Colorectal Cancer
Federation Francophone de Cancerologie Digestive 78
Testing effectiveness (Phase 2)Study completedNCT01558661
What this trial is testing

Axitinib (AG-013736) in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma

Who this might be right for
Adenoid Cystic Carcinoma
Memorial Sloan Kettering Cancer Center 33
Testing effectiveness (Phase 2)Looking for participantsNCT06890923
What this trial is testing

Nasal Foralumab in Patients With Non-Active Secondary Progressive Multiple Sclerosis

Who this might be right for
Non-Active Secondary Progressive Multiple Sclerosis
Tiziana Life Sciences LTD 55
Large-scale testing (Phase 3)Study completedNCT00046683
What this trial is testing

Efficacy/Safety of Frontline Alemtuzumab (Campath, MabCampath) vs Chlorambucil in Patients With Progressive B-Cell Lymphocytic Leukemia

Who this might be right for
B Cell Chronic Lymphocytic Leukemia
Genzyme, a Sanofi Company 284
Not applicableUnknownNCT06071169
What this trial is testing

The Effect of Progressive Relaxation Exercise on Nurses

Who this might be right for
Progressive Relaxation ExerciseComfortLife Satisfaction+1 more
TC Erciyes University 60
Testing effectiveness (Phase 2)UnknownNCT02682459
What this trial is testing

ACE-inhibitors in Extracapillary Glomerulonephritis

Who this might be right for
Extracapillary Glomerulonephritis
Monia Lorini 22
Large-scale testing (Phase 3)UnknownNCT00688194
What this trial is testing

Fulvestrant With or Without Lapatinib and/or Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer That Progressed After Previous Aromatase Inhibitor Therapy

Who this might be right for
Breast Cancer
Gruppo Italiano Mammella (GIM) 396
Testing effectiveness (Phase 2)Looking for participantsNCT06292923
What this trial is testing

Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Patients

Who this might be right for
Secondary Progressive Multiple Sclerosis
Tiziana Life Sciences LTD 54
Testing effectiveness (Phase 2)Study completedNCT01777594
What this trial is testing

Study of G-202 (Mipsagargin) as Second-Line Therapy Following Sorafenib in Hepatocellular Carcinoma

Who this might be right for
Advanced Adult Hepatocellular Carcinoma
GenSpera, Inc. 25
Testing effectiveness (Phase 2)Study completedNCT01777633
What this trial is testing

Palliative Re-irradiation for Progressive Diffuse Intrinsic Pontine Glioma (DIPG) in Children

Who this might be right for
Pediatric Malignant Brain Tumor -Diffuse Intrinsic Pontine Glioma
Hadassah Medical Organization 15
Not applicableStudy completedNCT00956475
What this trial is testing

Quality of Life in Younger Leukemia and Lymphoma Survivors

Who this might be right for
Anxiety DisorderCancer SurvivorFatigue+7 more
Case Comprehensive Cancer Center 48
Testing effectiveness (Phase 2)Ended earlyNCT00074334
What this trial is testing

TP-38 Toxin in Treating Young Patients With Recurrent or Progressive Supratentorial High-Grade Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Pediatric Brain Tumor Consortium 3
Not applicableLooking for participantsNCT06739967
What this trial is testing

Speech and Language Interventions for Italian People With PPA

Who this might be right for
Primary Progressive Aphasia(PPA)
Istituti Clinici Scientifici Maugeri SpA 30
Large-scale testing (Phase 3)Study completedNCT00666211
What this trial is testing

Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
Vanderbilt-Ingram Cancer Center 98
Testing effectiveness (Phase 2)Study completedNCT00448409
What this trial is testing

Activity of TroVax® Alone vs. TroVax® Plus GM-CSF in Patients With Prostate Cancer

Who this might be right for
Prostatic Neoplasms
The Methodist Hospital Research Institute 27
Testing effectiveness (Phase 2)Ended earlyNCT00750698
What this trial is testing

Exploratory Study of Erlotinib and SNDX-275 in Participants With Non-small Cell Lung Carcinoma Who Are Progressing on Erlotinib

Who this might be right for
Non Small Cell Lung Cancer
Syndax Pharmaceuticals 8
Load More Results